Data / Drug companies / Pharmadel LLC
Pharmadel LLC: 69 products in the FDA NDC directory, labeler code 55758
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Pharmadel LLC (labeler code 55758) lists 69 products in the FDA National Drug Code Directory, covering 39 finished drugs by generic name. By type: 69 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 1, 2026.
The request: Watch Pharmadel LLC (FDA labeler code 55758): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 55758
- Products in commercial distribution
- 69
- Packages
- 76
- Finished drugs by generic name
- 39
- Prescription products
- 0
- Over the counter products
- 69
- Flagged as original packager
- 65 of 65 products that carry the flag
- Started marketing in the last 12 months
- 6
- Products with a marketing end date set
- 3
- Earliest marketing start
- October 28, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 65 | 94.2% |
| Generic drugs (ANDA) | 4 | 5.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 69 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 19 | 27.5% |
| Ointment | 9 | 13% |
| Capsule, liquid filled | 8 | 11.6% |
| Tablet | 5 | 7.2% |
| Tablet, coated | 4 | 5.8% |
| Granule, for solution | 3 | 4.3% |
| Tablet, effervescent | 3 | 4.3% |
| Cream | 2 | 2.9% |
| Powder, for solution | 2 | 2.9% |
| Lozenge | 2 | 2.9% |
| Syrup | 2 | 2.9% |
| Powder | 2 | 2.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Sanatos | 55758-519 | Lozenge | Over the counter monograph drugs | August 1, 2026 |
| Sanatos | 55758-518 | Lozenge | Over the counter monograph drugs | August 1, 2026 |
| Broncolito Children | 55758-520 | Syrup | Over the counter monograph drugs | July 1, 2026 |
| Redness Relief | 55758-511 | Solution/ drops | Over the counter monograph drugs | July 1, 2026 |
| Sanatos Nighttime Relief | 55758-515 | Capsule, liquid filled | Over the counter monograph drugs | April 1, 2026 |
| Sanatos Daytime Relief | 55758-514 | Capsule, liquid filled | Over the counter monograph drugs | April 1, 2026 |
| Sanatos Nighttime | 55758-510 | Capsule, liquid filled | Over the counter monograph drugs | September 1, 2025 |
| Dolex Forte | 55758-509 | Tablet | Over the counter monograph drugs | August 12, 2025 |
| Sanatos Daytime | 55758-508 | Capsule, liquid filled | Over the counter monograph drugs | August 8, 2025 |
| Antigrip Cough and Cold | 55758-432 | Capsule, gelatin coated | Over the counter monograph drugs | August 1, 2025 |
| Rapidol | 55758-503 | Capsule, coated | Over the counter monograph drugs | July 17, 2025 |
| Niaflu | 55758-507 | Capsule, liquid filled | Over the counter monograph drugs | July 10, 2025 |
| Laxomil | 55758-504 | Tablet, coated | Over the counter monograph drugs | July 10, 2025 |
| DoloEar | 55758-506 | Liquid | Over the counter monograph drugs | May 15, 2025 |
| Dolodent Maximum Strength | 55758-505 | Liquid | Over the counter monograph drugs | May 14, 2025 |
| Rapidol Triple Antibiotic | 55758-440 | Ointment | Over the counter monograph drugs | November 4, 2024 |
| Rapidol | 55758-420 | Cream | Over the counter monograph drugs | November 4, 2024 |
| Artridon Glucosamine | 55758-030 | Ointment | Over the counter monograph drugs | November 4, 2024 |
| Antigrip Cough and Cold | 55758-502 | Tablet, effervescent | Over the counter monograph drugs | November 1, 2024 |
| Antigrip Flu | 55758-501 | Tablet, effervescent | Over the counter monograph drugs | November 1, 2024 |
| Antigrip Extra Strength | 55758-500 | Tablet, effervescent | Over the counter monograph drugs | November 1, 2024 |
| SanaTos X Children | 55758-443 | Liquid | Over the counter monograph drugs | August 1, 2024 |
| Kingskin Saca Callos | 55758-442 | Liquid | Over the counter monograph drugs | August 1, 2024 |
| MebendamaX Pinworm | 55758-441 | Tablet | Over the counter monograph drugs | August 1, 2024 |
| Rapidol 500 Extra Strength | 55758-439 | Tablet | Over the counter monograph drugs | August 1, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.